Download PDF
CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2022; 12(03): 280-285
DOI: 10.1055/s-0041-1740331
Original Article

Six-Minute Walk Test and its Correlation with Spirometry in Stable COPD Patients

B. Sai Krishna
1   Department of Respiratory Medicine, Kalinga Institute of Medical Sciences, KIIT Deemed-to-be-University, Bhubaneswar, Odisha, India
,
Amrut Kumar Mohapatra
1   Department of Respiratory Medicine, Kalinga Institute of Medical Sciences, KIIT Deemed-to-be-University, Bhubaneswar, Odisha, India
,
Debasis Behera
1   Department of Respiratory Medicine, Kalinga Institute of Medical Sciences, KIIT Deemed-to-be-University, Bhubaneswar, Odisha, India
,
Suman Kumar Jagaty
1   Department of Respiratory Medicine, Kalinga Institute of Medical Sciences, KIIT Deemed-to-be-University, Bhubaneswar, Odisha, India
,
Saswat Subhankar
1   Department of Respiratory Medicine, Kalinga Institute of Medical Sciences, KIIT Deemed-to-be-University, Bhubaneswar, Odisha, India
,
Rajesh Venkataram
2   Department of Respiratory Medicine, K.S. Hegde Medical College, Mangalore, Karnataka, India
,
D. P. Dash
1   Department of Respiratory Medicine, Kalinga Institute of Medical Sciences, KIIT Deemed-to-be-University, Bhubaneswar, Odisha, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Objectives An impaired exercise tolerance, the main feature in chronic obstructive pulmonary disease (COPD), occurs due to multiple factors. The 6-minute walk test (6MWT) is easy to perform, well-tolerated, and more reflective of activities of daily living. The facility of spirometry is unavailable in many areas of India, where 6MWT can be done easily. This study aims to compare the six-minute walk distance (6MWD) with various demographic, clinical, and spirometry parameters.

Materials and Methods A total of 118 consecutive stable COPD patients fitting the criteria were included in the study. Spirometry was performed in these patients before and after giving a short-acting bronchodilator. 6MWT was performed according to the ATS guidelines. All patients underwent the 6MWT after 10 minutes of spirometry. Statistical analysis was done using GraphPad calculator and SPSS 24.0.

Statistical Analysis All data were clubbed together in a single Excel chart. Statistical analysis was done using SPSS 24.0. Descriptive data are presented as mean ± standard deviation (SD). Qualitative data are presented as a percentage. Analysis of variance (ANOVA) was used to compare between means. The linear regression model was used to compare between variables. A p-value less than 0.05 was considered significant.

Results The majority of the patients were > 60 years of age (mean age = 62.99 ± 6.68 years) and comprised males and females in the ratio 5.9:1. Smoking was determined to be the most important predisposing factor for the development of COPD. There was a significant negative correlation between 6MWD, age, and smoking index (p = 0.0075 and 0.0295 respectively). The 6MWD showed a significant positive correlation with FEV1 (in liters), FEV1 (%), FVC (in liters), and FVC (%). The 6MWD (meters) and % predicted 6MWD showed a significant negative correlation with a drop in SpO2 after the 6MWT (r = –0.36; p = 0.000769, r = –0.3; p = 0.004, respectively).

Conclusion 6MWT can be used in cases of COPD where spirometry is unavailable as it correlates significantly with various parameters of the latter.

Keywords

COPD - 6MWT - 6MWD - spirometry


Publication History

Article published online:
30 December 2021

© 2021. Nitte (Deemed to be University). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Halpin DMG, Celli BR, Criner GJ. et al. The GOLD summit on chronic obstructive pulmonary disease in low- and middle-income countries. Int J Tuberc Lung Dis 2019; 23 (11) 1131-1141
    CrossrefPubMedGoogle Scholar
  • 2 Di Marco F, Terraneo S, Roggi MA. et al. Physical activity impairment in depressed COPD subjects. Respir Care 2014; 59 (05) 726-734
    CrossrefPubMedGoogle Scholar
  • 3 Watz H, Magnussen H. Komorbiditäten bei COPD. Internist (Berl) 2006; 47 (09) 895-896
    CrossrefPubMedGoogle Scholar
  • 4 Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001; 119 (01) 256-270
    CrossrefPubMedGoogle Scholar
  • 5 Statement ATS. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166 (01) 111-117
    CrossrefPubMedGoogle Scholar
  • 6 Miyamoto S, Nagaya N, Satoh T. et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000; 161 (2 Pt 1): 487-492
    CrossrefPubMedGoogle Scholar
  • 7 Chetta A, Aiello M, Foresi A. et al. Relationship between outcome measures of six-minute walk test and baseline lung function in patients with interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18 (02) 170-175
    PubMedGoogle Scholar
  • 8 Eaton T, Young P, Milne D, Wells AU. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005; 171 (10) 1150-1157
    CrossrefPubMedGoogle Scholar
  • 9 Enright PL, McBurnie MA, Bittner V. et al; Cardiovascular Health Study. The 6-min walk test: a quick measure of functional status in elderly adults. Chest 2003; 123 (02) 387-398
    PubMedGoogle Scholar
  • 10 Palaniappan Ramanathan R, Chandrasekaran B. Reference equations for 6-min walk test in healthy Indian subjects (25-80 years). Lung India 2014; 31 (01) 35-38
    CrossrefPubMedGoogle Scholar
  • 11 Menezes AM, Perez-Padilla R, Jardim JR. et al; PLATINO Team. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366 (9500): 1875-1881
    CrossrefPubMedGoogle Scholar
  • 12 Kodavala A. Correlation between forced expiratory volume in first second (FEV1) and 6 minute walk distance in moderate, severe and very severe chronic obstructive pulmonary disease. IOSR J Dent Med Sci 2013; 5 (02) 72-76
    CrossrefGoogle Scholar
  • 13 Thomas B, Sukumaran P. Study to find out the efficacy of 6 minute walk test in assessing response to medical intervention in chronic obstructive pulmonary disease patients. International Journal of Advances in Medicine 2016; 538-541
    CrossrefGoogle Scholar
  • 14 Naghshin R, Zaker MM, Afshar AE. Association between six-minute walk test and expiratory spirometry parameters in chronic obstructive pulmonary disease. Indian Heart J 2005; 6 (03) 59-63
    Google Scholar
  • 15 Grinish T, Khyati S, Mahendra PZ, Bhoomik P. A study of correlation of 6 minutes walk test (6MWT) & spirometry findings in COPD patients. Int J Res Med. 2017; 6 (03) 12-20
    Google Scholar
  • 16 Hajare R, Nagarwala R, Shyam A, Sancheti P. Correlation between 6-minute walk distance and spirometry parameters in stable chronic obstructive pulmonary disease patients. International Journal of Research in Medical Sciences 2018; 7 (01) 34
    CrossrefGoogle Scholar
  • 17 Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374 (9691): 733-743
    CrossrefPubMedGoogle Scholar
  • 18 Mortimer K, Gordon SB, Jindal SK, Accinelli RA, Balmes J, Martin II WJ. Household air pollution is a major avoidable risk factor for cardiorespiratory disease. Chest 2012; 142 (05) 1308-1315
    CrossrefPubMedGoogle Scholar
  • 19 Zhou Y, Wang D, Liu S. et al. The association between BMI and COPD: the results of two population-based studies in Guangzhou, China. COPD 2013; 10 (05) 567-572
    CrossrefPubMedGoogle Scholar
  • 20 Shimray A, Singh W, Ningshen K, Kanan W, Devi A, Laishram R. Association body mass index and spirometric lung function in chronic obstructive pulmonary disease (COPD) patients attending RIMS Hospital, Manipur. Journal of Medical Society 2014; 28 (03) 157
    CrossrefGoogle Scholar
  • 21 Wu Z, Yang D, Ge Z, Yan M, Wu N, Liu Y. Body mass index of patients with chronic obstructive pulmonary disease is associated with pulmonary function and exacerbations: a retrospective real world research. J Thorac Dis 2018; 10 (08) 5086-5099
    CrossrefPubMedGoogle Scholar
  • 22 Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 2008; 177 (07) 743-751
    CrossrefPubMedGoogle Scholar
  • 23 Gosker HR, Engelen MP, van Mameren H. et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002; 76 (01) 113-119
    CrossrefPubMedGoogle Scholar
  • 24 Ozalevli S, Ozden A, Gocen Z, Cimrin AH. Comparison of six-minute walking tests conducted with and without supplemental oxygen in patients with chronic obstructive pulmonary disease and exercise-induced oxygen desaturation. Ann Saudi Med 2007; 27 (02) 94-100
    CrossrefPubMedGoogle Scholar
  • 25 Woon WT, Fang WF, Lin MC, Wang YH. Six-minute walking test in patients with chronic obstructive pulmonary disease. Thorac Med 2005; 20: 431-437
    Google Scholar
  • 26 Gupta SS, Gothi D, Narula G, Sircar J. Correlation of BMI and oxygen saturation in stable COPD in Northern India. Lung India 2014; 31 (01) 29-34
    CrossrefPubMedGoogle Scholar
  • 27 Golpe R, Pérez-de-Llano LA, Méndez-Marote L, Veres-Racamonde A. Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patients. Respir Care 2013; 58 (08) 1329-1334
    CrossrefPubMedGoogle Scholar